Oh Tomboy it is a shame that MCR will likely drop off the radar, I will miss your Treatises, all the best with POS, hope its. a winner for you.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%